Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. | | |
|
The subcutaneous administration of CBD could make a significant impact on patient outcomes, according to new findings presented at the Heart Failure Society of America's annual meeting in Cleveland. The subcutaneous administration of CBD could make a significant impact on patient outcomes, according to new findings presented at the Heart Failure Society of America's annual meeting in Cleveland. | | |
|
Post-TAVR stroke is rare, but it can be fatal. A new study in Catheterization and Cardiovascular Interventions examined the issue in great detail, focusing on more than 2,700 patients treated over a two-year stretch. Post-TAVR stroke is rare, but it can be fatal. A new study in Catheterization and Cardiovascular Interventions examined the issue in great detail, focusing on more than 2,700 patients treated over a two-year stretch. | | |
|
This encouraged the study’s authors, who had feared any history of smoking on a regular basis would do permanent, irreversible damage to a patient's cardiovascular health. This encouraged the study’s authors, who had feared any history of smoking on a regular basis would do permanent, irreversible damage to a patient's cardiovascular health. | | |
|
Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder. Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder. | | |
|
How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question. How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question. | | |
|
Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning. Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning. | | |
|
The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure. The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure. | | |
|
How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question. How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question. | | |
|
Access to cannabis is skyrocketing across the United States, but much more research is still needed on its long-term side effects. Access to cannabis is skyrocketing across the United States, but much more research is still needed on its long-term side effects. | | |
|
Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. | | |
|
A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety. A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety. | | |
|
The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues. The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues. | | |
|
